394 related articles for article (PubMed ID: 29051464)
1. Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies.
Callejo A; Sedó-Cabezón L; Juan ID; Llorens J
Toxics; 2015 Jul; 3(3):268-293. PubMed ID: 29051464
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies.
Tang Q; Wang X; Jin H; Mi Y; Liu L; Dong M; Chen Y; Zou Z
Eur J Pharm Biopharm; 2021 Jun; 163():60-71. PubMed ID: 33775853
[TBL] [Abstract][Full Text] [Related]
3. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model.
Murphy D; Daniel SJ
Otolaryngol Head Neck Surg; 2011 Sep; 145(3):452-7. PubMed ID: 21521888
[TBL] [Abstract][Full Text] [Related]
4. Current Strategies to Combat Cisplatin-Induced Ototoxicity.
Yu D; Gu J; Chen Y; Kang W; Wang X; Wu H
Front Pharmacol; 2020; 11():999. PubMed ID: 32719605
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of cisplatin ototoxicity and progress in otoprotection.
Rybak LP
Curr Opin Otolaryngol Head Neck Surg; 2007 Oct; 15(5):364-9. PubMed ID: 17823555
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Cisplatin-Induced Ototoxicity and Prevention.
Rybak LP; Mukherjea D; Ramkumar V
Semin Hear; 2019 May; 40(2):197-204. PubMed ID: 31036996
[TBL] [Abstract][Full Text] [Related]
7. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
[TBL] [Abstract][Full Text] [Related]
8. Optimal N-acetylcysteine concentration for intratympanic injection to prevent cisplatin-induced ototoxicity in guinea pigs.
Chen BC; Lin LJ; Lin YC; Lee CF; Hsu WC
Acta Otolaryngol; 2022 Feb; 142(2):127-131. PubMed ID: 35287541
[TBL] [Abstract][Full Text] [Related]
9. Effects of natural products on cisplatin ototoxicity and chemotherapeutic efficacy.
Rybak LP; Alberts I; Patel S; Al Aameri RFH; Ramkumar V
Expert Opin Drug Metab Toxicol; 2023 Sep; 19(9):635-652. PubMed ID: 37728555
[TBL] [Abstract][Full Text] [Related]
10. Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity.
Mukherjea D; Dhukhwa A; Sapra A; Bhandari P; Woolford K; Franke J; Ramkumar V; Rybak L
Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):965-982. PubMed ID: 32757852
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections.
Hill GW; Morest DK; Parham K
Otol Neurotol; 2008 Oct; 29(7):1005-11. PubMed ID: 18716567
[TBL] [Abstract][Full Text] [Related]
12. Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity.
Kim KH; Lee B; Kim YR; Kim MA; Ryu N; Jung DJ; Kim UK; Baek JI; Lee KY
Cell Death Dis; 2018 Aug; 9(8):827. PubMed ID: 30068942
[TBL] [Abstract][Full Text] [Related]
13. Intratympanic Diltiazem-Chitosan Hydrogel as an Otoprotectant Against Cisplatin-Induced Ototoxicity in a Mouse Model.
Naples JG; Ruckenstein MJ; Singh J; Cox BC; Li D
Otol Neurotol; 2020 Jan; 41(1):115-122. PubMed ID: 31746818
[TBL] [Abstract][Full Text] [Related]
14. Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients.
Viglietta V; Shi F; Hu QY; Ren Y; Keilty J; Wolff H; McCarthy R; Kropp J; Weber P; Soglia J
Invest New Drugs; 2020 Oct; 38(5):1463-1471. PubMed ID: 32157599
[TBL] [Abstract][Full Text] [Related]
15. Molecular Characteristics of Cisplatin-Induced Ototoxicity and Therapeutic Interventions.
Tan WJT; Vlajkovic SM
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003734
[TBL] [Abstract][Full Text] [Related]
16. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo effects of lutein against cisplatin-induced ototoxicity.
Roldán-Fidalgo A; Martín Saldaña S; Trinidad A; Olmedilla-Alonso B; Rodríguez-Valiente A; García-Berrocal JR; Ramírez-Camacho R
Exp Toxicol Pathol; 2016 Apr; 68(4):197-204. PubMed ID: 26850526
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin ototoxicity and protection: clinical and experimental studies.
Rybak LP; Mukherjea D; Jajoo S; Ramkumar V
Tohoku J Exp Med; 2009 Nov; 219(3):177-86. PubMed ID: 19851045
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological intervention in the field of ototoxicity.
Laurell G
HNO; 2019 Jun; 67(6):434-439. PubMed ID: 30993373
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity.
Chen Y; Gu J; Liu J; Tong L; Shi F; Wang X; Wang X; Yu D; Wu H
Int J Nanomedicine; 2019; 14():4211-4227. PubMed ID: 31239676
[No Abstract] [Full Text] [Related]
[Next] [New Search]